Robert G. Wilkins

Endovalve, Inc. develops percutaneous mitral valve replacement system. It designs for insertion during a minimally invasive surgical procedure, allowing a complete valve replacement without the risks and complications associated with both sternotomy and cardiopulmonary bypass. The company was founded by Howard Herrmann in June 2005 and is headquartered in Princeton, NJ.

The Society of Critical Care Medicine is a non-profit medical organization founded in 1970. The non-profit company is based in Des Plaines, IL. The company promotes the practice of critical care.

Battelle Ventures LP seeks investment opportunities in technology companies located in the US. The fund targets companies operating in the fields of energy & environment, health & life sciences, information technology, energy and advanced materials/nanotechnology. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 10 to 12 million. It also makes follow-on investments.

NellOne Therapeutics, Inc. develops and produces soft-tissue regenerative medicine. It develops a new class of therapeutic products that will shift the paradigm of tissue healing after acute injury from scarring to complete regeneration of form and function. The company’s product NELL1 is a signaling protein that triggers pathways for tissue growth and maturation in a variety of tissues including heart muscle, skeletal muscle and blood vessels. NellOne Therapeutics was founded by Cymbeline Tancongco Culiat and Tracy S. Warren in 2008 and is headquartered in Oak Ridge, TN.

Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.

Micro Interventional Devices, Inc. designs, develops and manufactures minimally invasive and catheter-based technologies that address unmet needs in cardiac surgery and interventional cardiology. The firm’s Permaseal and Endovalve technologies provide for the one-two punch in mitral valve repair, one access and spontaneous closure to left-sided structures and two, 360 degrees anchoring capabilities. The company was founded by Michael Whitman in May 2010 and is headquartered in Newtown, PA.

Ascendance Biotechnology, Inc. engages in the sale of cell-based assay products. It offers Hepregen and ESI Bio. The firm also offers stem cell technology. The company was founded by Vincent R. Zurawski, Jr. and Jeffrey D. Janus is headquartered in Alameda, CA.